1. Home
  2. Studies
  3. The Corona Innovation Race in Science
Jasmina Kirchhoff / Armin Mertens / Marc Scheufen IW-Report No. 17 5. May 2020 The Corona Innovation Race in Science

This report is an analysis of the scientific publications on the fight against the corona pandemic and its significance for Germany as a pharmaceutical location.

Download PDF
The Corona Innovation Race in Science
Jasmina Kirchhoff / Armin Mertens / Marc Scheufen IW-Report No. 17 5. May 2020

The Corona Innovation Race in Science

IW-Report

Download PDF

Share this article:

or copy the following link:

The link was added to your clipboard!

This report is an analysis of the scientific publications on the fight against the corona pandemic and its significance for Germany as a pharmaceutical location.

The corona pandemic and the associated restrictions on social and economic life have been affecting all our lives around the world for several weeks now. Besides, the possible strategy of aiming for herd immunity by infecting 60 to 70 percent of the population, a suitable vaccine is the great hope to restore the “old normality”, as Olaf Scholz calls it, in the near future. Against this background, science and pharmaceutical companies are looking for innovations.

This study examines the flood of scientific publications on the basis of bibliometric data from “Europe PubMed Central” to analyze the spillover effects from science to the pharmaceutical innovation process. The analysis of the scientific publications from December 1, 2019, to April 15, 2020, over time and in comparison to other countries, reveals a flood of new contributions and findings that should help to better understand the virus “SARS-CoV-2” in order to develop an vaccine against this background. In addition to the quantitatively impressive number of publications, the quality of research shows that Germany is a leader in scientific research. This leading role of Germany in the fight against the virus motivates a detailed examination. In addition to an analysis according to locations and institutions, which provides a better understanding of Germany’s research performance, the focus will also be on the significance of this for the pharmaceutical industry in Germany.

 

 

Download PDF
The Corona Innovation Race in Science
Jasmina Kirchhoff / Armin Mertens / Marc Scheufen IW-Report No. 17 5. May 2020

Jasmina Kirchhoff / Armin Mertens / Marc Scheufen: Der Corona-Innovationswettlauf in der Wissenschaft – Eine Analyse der wissenschaftlichen Publikationen zur Bekämpfung der Corona-Pandemie und die Bedeutung für den Pharma-Standort Deutschland

IW-Report

Download PDF

Share this article:

or copy the following link:

The link was added to your clipboard!

More on the topic

Read the article
Industry policy recommendations for a sustainable pharmaceutical industry
Jasmina Kirchhoff IW-Policy Paper No. 22 24. September 2021

More medicines "made in Germany" via international networking

The Corona pandemic has put the German pharmaceutical industry more than ever in the focus of political and social discussions. At an unprecedented speed, pharmaceutical companies have developed and brought to market four vaccines approved in Europe – German ...

IW

Read the article
Michael Grömling / Jasmina Kirchhoff IW-Trends No. 4 10. November 2020

Production Structures and Supply Chains in the German Pharmaceutical Sector

The corona pandemic has reinforced earlier calls for national sovereignty over critical technologies, with policymakers, the business world and society as a whole focusing their attention particularly on the pharmaceutical industry.

IW

More about this topic

Content element with id 8880 Content element with id 9713